Search Results - "SCHLENDORF, KELLY H."

Characterization of human atherosclerosis by optical coherence tomography by YABUSHITA, Hiroshi, BOUMA, Brett E, TEARNEY, Guillermo J, HOUSER, Stuart L, ARETZ, H. Thomas, JANG, Ik-Kyung, SCHLENDORF, Kelly H, KAUFFMAN, Christopher R, SHISHKOV, Milen, KANG, Dong-Heon, HALPERN, Elkan F

“…High-resolution visualization of atherosclerotic plaque morphology may be essential for identifying coronary plaques that cause acute coronary events. Optical…”
Get full text

Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography by TEARNEY, Guillermo J, YABUSHITA, Hiroshi, HOUSER, Stuart L, ARETZ, H. Thomas, JANG, Ik-Kyung, SCHLENDORF, Kelly H, KAUFFMAN, Christopher R, SHISHKOV, Milen, HALPERN, Elkan F, BOUMA, Brett E

“…Macrophage degradation of fibrous cap matrix is an important contributor to atherosclerotic plaque instability. An imaging technology capable of identifying…”
Get full text

Limitations of the Framingham risk score are now much clearer by Schlendorf, Kelly H, Nasir, Khurram, Blumenthal, Roger S

Get full text

Coronary Allograft Vasculopathy: From Predictably Unpredictable to Unpredictably Predictable by Schlendorf, Kelly H.

Get full text

Perioperative Blood Product Use: A Comparison Between HeartWare and HeartMate II Devices by Haglund, Nicholas A., MD, Davis, Mary E., MS, CCRP, Tricarico, Nicole M., BS, Ahmad, Rashid M., MD, DiSalvo, Thomas G., MD, MPH, Keebler, Mary E., MD, Schlendorf, Kelly H., MD, MHS, Wigger, Mark A., MD, Stulak, John M., MD, Maltais, Simon, MD, PhD

“…Background The HeartWare (HW) (Framingham, MA) and the HeartMate II (HM II) (Thoratec Inc, Pleasanton, CA) continuous-flow left ventricular assist devices…”
Get full text

Transcatheter Aortic Valve Replacement and Surgical Aortic Valve Replacement Outcomes in Left Ventricular Assist Device Patients with Aortic Insufficiency by Rali, Aniket S, Taduru, Siva S, Tran, Lena E, Ranka, Sagar, Schlendorf, Kelly H, Barker, Colin M, Shah, Ashish S, Lindenfeld, JoAnn, Zalawadiya, Sandip K

“…Worsening aortic insufficiency (AI) is a known sequela of prolonged continuous-flow left ventricular assist device (LVAD) support with a significant impact on…”
Get full text

Does Renal Dysfunction and Method of Bridging Support Influence Heart Transplant Graft Survival? by Haglund, Nicholas A., MD, Feurer, Irene D., PhD, Dwyer, Jamie P., MD, Stulak, John M., MD, DiSalvo, Thomas G., MD, MPH, Keebler, Mary E., MD, Schlendorf, Kelly H., MD, MHS, Wigger, Mark A., MD, Maltais, Simon, MD, PhD

“…Background Renal insufficiency is common in status 1B patients supported with inotropes or a continuous flow left ventricular device (CF-LVAD) as a bridge to…”
Get full text

Mechanical Circulatory Support and Heart Transplantation: Donor and Recipient Factors Influencing Graft Survival by Maltais, Simon, MD, PhD, Jaik, Nikhil P., MD, Feurer, Irene D., PhD, Wigger, Mark A., MD, DiSalvo, Thomas G., MD, Schlendorf, Kelly H., MD, Ahmad, Rashid M., MD, Lenihan, Daniel J., MD, Stulak, John M., MD, Keebler, Mary E., MD

“…Background Mechanical circulatory support is an accepted strategy to bridge patients to heart transplantation (HTx). Among mechanical circulatory support…”
Get full text

Institutional volume of heart transplantation with left ventricular assist device explantation influences graft survival by Haglund, Nicholas A., MD, Feurer, Irene D., PhD, Ahmad, Rashid M., MD, DiSalvo, Thomas G., MD, MPH, MBA, Lenihan, Daniel J., MD, Keebler, Mary E., MD, Schlendorf, Kelly H., MD, MHS, Stulak, John M., MD, Wigger, Mark A., MD, Maltais, Simon, MD, PhD

“…Background There are increasing numbers of patients undergoing orthotopic heart transplantation (OHT) with left ventricular assist device (LVAD) explantation…”
Get full text

Unknown Risks of Transplantation in Adults with Congenital Heart Disease by Rali, Aniket S, Weingarten, Angela, Sandhaus, Emily, Gupta, Richa, Rollins, Allman, Bichell, David, Do, Nhue, Brinkley, D. Marshall, Schlendorf, Kelly H, Freno, Daniel, Balsara, Keki, Menachem, Jonathan N

Get full text

Heart-kidney transplantation: Is 2 really better than 1? by Schlendorf, Kelly H., Hsich, Eileen M.

Get full text

Early outcomes using hepatitis C–positive donors for cardiac transplantation in the era of effective direct-acting anti-viral therapies by Schlendorf, Kelly H., Zalawadiya, Sandip, Shah, Ashish S., Wigger, Mark, Chung, Chan Y., Smith, Sarah, Danter, Matthew, Choi, Chun W., Keebler, Mary E., Brinkley, D. Marshall, Sacks, Suzanne Brown, Ooi, Henry, Perri, Roman, Awad, Joseph A., Lewis, Samuel, Hayes, Rachel, O’Dell, Heather, Darragh, Callie, Carver, Alicia, Edmonds, Cori, Ruzevich-Scholl, Shelley, Lindenfeld, JoAnn

“…Given the shortage of suitable donor hearts for cardiac transplantation, and the favorable safety and efficacy of current agents used to treat hepatitis C…”
Get full text

Single-cell RNA-sequencing identifies unique cell-specific gene expression profiles in high-grade cardiac allograft vasculopathy by Amancherla, Kaushik, Schlendorf, Kelly H, Chow, Nelson, Sheng, Quanhu, Freedman, Jane E, Rathmell, Jeffrey C

“…Cardiac allograft vasculopathy (CAV) is the leading cause of late graft failure and mortality after heart transplantation (HT). Current strategies for early…”
Get full text

Venoarterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock by Keebler, Mary E., Haddad, Elias V., Choi, Chun W., McGrane, Stuart, Zalawadiya, Sandip, Schlendorf, Kelly H., Brinkley, D. Marshall, Danter, Matthew R., Wigger, Mark, Menachem, Jonathan N., Shah, Ashish, Lindenfeld, JoAnn

“…Venoarterial extracorporeal membrane oxygenation has emerged as a viable treatment for patients in cardiogenic shock with biventricular failure and pulmonary…”
Get full text

HCV Positive Allograft Use in Heart Transplant: A Silver Lining to an Epidemic by DEVORE, ADAM D., SCHLENDORF, KELLY H.

Get full text

Integrating risks and benefits: pretransplant assessment and patient selection for heart transplantation in adult congenital heart disease by Lewis, Matthew J, Schlendorf, Kelly H, Reardon, Leigh C

“…The number of adult congenital heart disease (ACHD) patients presenting for consideration of heart transplantation continues to grow. Comprehensive…”
Get full text

Transplanting COVID-19–Positive Donor Hearts: A Previous Threat, Now an Opportunity by Schlendorf, Kelly H., Woolley, Ann E.

Get full text

Expanding the donor pool to improve outcomes for adults with complex congenital heart disease by Menachem, Jonathan N., Patel, Chetan B., Schlendorf, Kelly H., Shah, Ashish S., Schroder, Jacob N., DeVore, Adam D.

Get full text

Sizing heart transplant donors in adults with congenital heart disease by Clark, Daniel E., Byrne, Ryan D., Mazurek, Jeremy A., Opotowsky, Alexander R., Schlendorf, Kelly H., Xu, Meng, Zalawadiya, Sandip, Menachem, Jonathan N.

“…Optimal donor sizing for heart transplantation (HT) in adults with congenital heart disease (CHD) remains unclear, given the propensity for pulmonary…”
Get full text

Utilization of hepatitis C virus–infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement by Aslam, Saima, Grossi, Paolo, Schlendorf, Kelly H., Holm, Are M., Woolley, Ann E., Blumberg, Emily, Mehra, Mandeep R., Mehra, Mandeep R., Silveira, Fernanda P., Teuteberg, Jeffrey, Crespo, Maria, Lyster, Haifa, Lourenco, Laura, Machado, Sara, Shullo, Michael, Hartwig, Matthew, Peraskeva, Miranda, Wolfe, Cameron, Khush, Kiran, Ison, Michael, Hall, Shelley, Mooney, Joshua, Ivulich, Steve, Cypel, Marcelo, Pretorius, Victor, Uber, Patricia, Kransdorf, Evan, Cochrane, Adam, Glanville, Alan, Gray, Jennifer

“…The advent of therapies for successful treatment of hepatitis C virus has allowed the heart and lung transplant community to re-explore the use of hepatitis C…”
Get full text